Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

BACKGROUND: The use of fixed-dose combination nucleoside reverse-transcriptase inhibitors (NRTIs) with a nonnucleoside reverse-transcriptase inhibitor or a ritonavir-boosted protease inhibitor is recommended as initial therapy in patients with human immunodeficiency virus type 1 (HIV-1) infection, b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sax, Paul E., Tierney, Camlin, Collier, Ann C., Fischl, Margaret A., Mollan, Katie, Peeples, Lynne, Godfrey, Catherine, Jahed, Nasreen C., Myers, Laurie, Katzenstein, David, Farajallah, Awny, Rooney, James F., Ha, Belinda, Woodward, William C., Koletar, Susan L., Johnson, Victoria A., Geiseler, P. Jan, Daar, Eric S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2800041/
https://ncbi.nlm.nih.gov/pubmed/19952143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0906768
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados